[1] |
De Backer O, Arnous S, Ihlemann N, et al. Percutaneous left atrial appendage occlusion for stroke prevention in atrial fibrillation: an updat [J]. Open Heart, 2014, 1(1): e000020.
|
[2] |
Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation [J]. Ann Thorac Surg, 1996, 61(2): 755-759.
|
[3] |
Calkins H, Kuck KH, Cappato R, et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design : a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society [J]. Heart Rhythm, 2012, 9(4): 632-696. e21.
|
[4] |
European Heart Rhythm Association, European Association for Cardio-thoracic Surgery, Camm AJ, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology(ESC) [J]. Eur Heart J, 2010, 31(19): 2369-2429.
|
[5] |
邢小飞,刘楠楠,周微微, 等. 经食管超声心动图与增强CT在心房颤动患者拟行射频消融术前左心耳血栓检测中的研究 [J]. 中国超声医学杂志, 2017, 33(8): 694-697.
|
[6] |
Sievert H, Lesh MD, Trepels T, et al. Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in hight-risk patients with atrial fibrillation:early clinical experience [J]. Circulation, 2002, 105(16): 1887-1889.
|
[7] |
樊友启,杨倩,蒋峻, 等. 经导管左心耳封堵术预防房颤血栓栓塞 [J]. 中华急诊医学杂志, 2014, 23(7): 735-739.
|
[8] |
Schwartzman D, Katz WE, Smith AJ, et al. Malpositioning of a left atrial appendage occlusion device? A case with implications for percutaneous transcatheter left atrial appendage occlusion device therapy [J]. Heart Rhythm, 2007, 4(5): 648-650
|
[9] |
Holmes DR, Reddy VY, Turi ZG, et al. Percutaneous closure of the left atrial appendage versus warfin therapy for prevention of stroke in patients with atrialfibrillation: a randomized non-inferiority trial [J]. Lacet, 2009, 374(9689): 534-542.
|
[10] |
Chun KR, Bordignon S, Urban V, et al. Left atrial appendage closure followed by 6 weeks of antithrombotic therapy: a prospective single-center experience [J]. Heart Rhythm, 2013, 10(12): 1792-1799.
|
[11] |
Viles-Gonzalez JF, Kar S, Douglas P, et a1. The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation:a PROTECT AF (Pereutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients Witll Atrial Fibrillation)substudy [J]. J Am Coil Cardiol, 2012, 59(10): 923-929.
|
[12] |
Meincke F, Schmidt-Salzmann M, Kreidel F, et al. New technical and anticoagulation aspects for left atrial appendage closure using the WATCHMAN? device in patients not taking warfarin [J]. EuroIntervention, 2013, 9(4): 463-468.
|
[13] |
Bai R, Horton RP, DI Biase L, et al. Intraprocedural and long-term incomplete occlusion of the left atrial appendage following placement of the WATCHMAN device: a single center experience [J]. J Cardiovasc Electrophysiol, 2012, 23(5): 455-461.
|
[14] |
Konoyza TF, Kahlert P, Plicht B, et a1. Risk factors for thrombus formation on the Amplatzer Cardiac Plug after left atrail appendage occlusion [J]. JACC Cardiovasc Interv, 2013, 6(6): 606-613.
|